Related Experiment Videos
Minimally invasive surgery and clinical decision-making for pediatric malignancy
J H Waldhausen1, D Tapper, R S Sawin
1Department of Surgery, Children's Hospital and Regional Medical Center University of Washington School of Medicine, Seattle 98105, USA.
Surgical Endoscopy
|March 31, 2000
Summary
Minimally invasive surgery (MIS) provides safe and accurate tissue biopsies for pediatric cancer patients. Treatment decisions based on MIS biopsies are reliable, ensuring appropriate care.
Area of Science:
- Pediatric Oncology
- Surgical Pathology
- Minimally Invasive Surgery
Background:
- Minimally invasive surgery (MIS) is a preferred method for obtaining biopsy specimens in pediatric oncology.
- Assessing the safety and reliability of MIS for diagnostic purposes is crucial.
Purpose of the Study:
- To evaluate the safety and reliability of minimally invasive surgery for obtaining biopsy specimens in pediatric cancer patients.
- To determine the accuracy of treatment decisions based on MIS-acquired tissue.
Main Methods:
- A retrospective review of 62 MIS procedures performed on 59 pediatric oncology patients between January 1994 and July 1998.
- Analysis of complications, biopsy results, and patient outcomes following MIS procedures.
Main Results:
- The study included 59 patients (32 boys, 27 girls; average age 8.8 years) who underwent 62 MIS procedures (47 thoracoscopic, 15 laparoscopic).
- Diagnostic accuracy was 100%, with no cases of inadequate treatment based on MIS biopsy results.
- Procedures included initial biopsies, resectability determination, second-look exams, lung biopsies, and mediastinal mass biopsies/resections.
Conclusions:
- Minimally invasive surgery is a safe and highly accurate technique for tissue acquisition in pediatric oncology.
- Treatment decisions derived from MIS biopsies are reliable and can be made with confidence.